The Global Peripherally Inserted Central Catheters (PICC) Market To Progress At A CAGR of 5.23% During The Study Period (2018-26)

New York, USA, March 09, 2022 (GLOBE NEWSWIRE) — The Global Peripherally Inserted Central Catheters (PICC) Market To Progress At A CAGR of 5.23% During The Study Period (2018-26)

As per DelveInsight analysis, the Peripherally Inserted Central Catheters market size is increasing owing to the factors such as rising incidence of cancer, infectious diseases, growing demand for PICC, integration of advanced technologies to the existing products, new product launches by leading players, among others.

DelveInsight’s Peripherally Inserted Central Catheters Market Insights report provides the current and forecast market, upcoming device innovation, individual leading companies market shares, challenges, market drivers, barriers, and trends, and key Peripherally Inserted Central Catheters companies in the market.

Key Takeaways from the Global Peripherally Inserted Central Catheters Market

• According to DelveInsight analysis, North America is anticipated to dominate the global Peripherally Inserted Central Catheters market during the forecast period.
• The leading Peripherally Inserted Central Catheters companies including AngioDynamics Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, Teleflex Incorporated., Argon Medical Devices, Inc., Cook, Theragenics Corporation, ICU Medical, Inc., Medical Components, Inc., Access Vascular, Vygon, Biowy Corporation, Polymedicure, Footprint Medical Inc., Novamed Medical Systems, INSUNG MEDICAL Co., Ltd., SILMAG, pfm medical ag, Equipos de Biomedicina de México, S.A. de C.V, Healthline Medical Products,  and others are currently dominating the Peripherally Inserted Central Catheters market.
• As per DelveInsight analysis, the global Peripherally Inserted Central Catheters market size is expected to reach USD 1.1 billion by 2026.
• In January 2020, AngioDynamics Inc. acquired the C3 Wave PICC tip location system from Medical Components Inc.
• In February 2020, Access Vascular, Inc received the FDA approval for HydroPICC a Peripherally Inserted Central Catheter (PICC) intended for short or long-term use.

For more insights about the Peripherally Inserted Central Catheters market; download the snapshot of the key highlights entailed in the Peripherally Inserted Central Catheters Market Report

Peripherally Inserted Central Catheters

A Peripherally Inserted Central Catheter (PICC), also known as a Peripherally Inserted Central Catheter (PICC) line, is a long, thin tube that is inserted through a vein in the arm and passed to larger veins near the heart. In rare cases, a PICC line may be inserted into the leg. A PICC line can help to avoid the pain of frequent needle sticks and reduce the risk of irritation to the arm’s smaller veins.
A PICC line necessitates meticulous care and monitoring for complications such as infection and blood clots.

Peripherally Inserted Central Catheters Market Insights

North America is anticipated to dominate the overall Peripherally Inserted Central Catheters (PICC) market among all countries during the forecast period. This domination is due to the favorable reimbursement scenario, well-established guidelines for PICC use in the region along with the presence of enhanced and advanced healthcare facilities.

Further, In the United States, the rising cases of chronic disorder such as cancer, respiratory disorders, gastrointestinal disorder in the region is likely to increase the demand for PICC.

Moreover, the presence of key Peripherally Inserted Central Catheters market players such as Cook, AngioDynamics, and Becton, Dickinson and Company, among others is also projected to augment the Peripherally Inserted Central Catheters market.

For further information about the scenario of the Peripherally Inserted Central Catheters market in other geographies, visit Peripherally Inserted Central Catheters Market

Peripherally Inserted Central Catheters Market Dynamics

Rising incidence of cancer across the globe has increased the demand for peripherally inserted central catheters (PICC). This is because PICCs are used to administer chemotherapy drugs directly into the veins and avoid irritation in the veins. In addition, an increase in sedentary lifestyle such as tobacco use, alcohol use, unhealthy diet, physical inactivity are risk factors for cancer (and other noncommunicable diseases) and can cause a rise in carcinoma cases. 

Moreover, an increase in parental nutrition for the patients suffering from a variety of disorders or conditions that impair food intake, nutrient digestion, or absorption is also anticipated to increase the demand for peripherally inserted central catheters. Additionally, recent PICC product approval is also expected to contribute to the growth of the global Peripherally Inserted Central Catheters market.

However, an increase in the prevalence of deep vein thrombosis, and a high risk of bloodstream infections are some of the factors that are likely to impede the Peripherally Inserted Central Catheters market growth.

Get a sneak peek at the Peripherally Inserted Central Catheters market dynamics @ Peripherally Inserted Central Catheters Market Dynamics Analysis

Scope of the Peripherally Inserted Central Catheters Market Report

• Coverage: Global
• Study Period: 2021-2026
• PICC Market Segmentation By Product Type– Power Injected Peripherally Inserted Central Catheters, Non-Power Injected/Conventional Peripherally Inserted Central Catheters
• PICC Market Segmentation by Design – Single Lumen, Double Lumen, Triple Lumen
• PICC Market Segmentation By End-User – Hospitals, Ambulatory Surgical Centers, and Others
• PICC Market Segmentation By Geography – North America, Europe, Asia-Pacific, and Rest of World
• Key Peripherally Inserted Central Catheters Companies – AngioDynamics Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, Teleflex Incorporated., Argon Medical Devices, Inc., Cook, Theragenics Corporation, ICU Medical, Inc., Medical Components, Inc., Access Vascular, Vygon, Biowy Corporation, Polymedicure, Footprint Medical Inc., Novamed Medical Systems, INSUNG MEDICAL Co., Ltd., SILMAG, pfm medical ag, Equipos de Biomedicina de México, S.A. de C.V, Healthline Medical Products, and others.
• Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View

DelveInsight Analysis: The Peripherally Inserted Central Catheters market is expected to grow at a CAGR of 5.23% during the forecast period (2021-26)

Which MedTech key players in the Peripherally Inserted Central Catheters market are set to emerge as the trendsetter explore @ Leading Peripherally Inserted Central Catheters Access Device Companies

Table of Contents 

Learn more about the Peripherally Inserted Central Catheters placement @ Peripherally Inserted Central Catheters (PICC) Line

Related Reports

Peripheral Vascular Devices Market

Peripheral Vascular Devices Market Insight, Competitive Landscape, and Market Forecast, 2026 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key Peripheral Vascular Devices companies such as Medtronic, Boston Scientific Corporation, B. Braun Melsungen AG, Braile Biomedica, JOTEC GmbH, Edwards Life Sciences Corporation, among others.

Peripheral Vascular Clot Management Interventions Market

Peripheral Vascular Clot Management Interventions Market Insight, Competitive Landscape, and Market Forecast, 2026 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key Peripheral Vascular Clot Management Interventions companies such as Boston Scientific Corporation, Penumbra Inc, Medtronic, Koninklijke Philips N.V., Edward LifeSciences Corporation, Cardinal Health, among others.

Radiologic Cancer Therapy Market

Radiologic Cancer Therapy Market Insight, Competitive Landscape, and Market Forecast, 2026 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key Radiologic Cancer Therapy companies such as Accuray, Inc., Nordion Inc., Varian Medical Systems, IsoRay, Inc., Ion Beam Applications SA, among others.

Surgery and Radiation Therapy in Brain Cancer Market

Surgery and Radiation Therapy in Brain Cancer Market Insight, Competitive Landscape, and Market Forecast, 2026 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key Surgery and Radiation Therapy in Brain Cancer companies such as Accuray Incorporated, Ion Beam Applications SA, Eckert & Ziegler, Hitachi, Ltd., Varian Medical Systems Inc., GT Medical Technologies Inc., among others.

Cancer Diagnostic Market

Cancer Diagnostic Market Insight, Competitive Landscape, and Market Forecast, 2026 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key Cancer Diagnostic companies such as Pillar Biosciences, Inc., Hologic Inc., CD Genomics, Natera, Inc., Agendia Inc., Biodesix Inc., INOVIQ  Ltd., HTG Molecular Diagnostics Inc., Bio-Rad Laboratories, among others.

Liquid Biopsy in Cancer Diagnostics Market

Liquid Biopsy in Cancer Diagnostics Market Insight, Competitive Landscape, and Market Forecast, 2026 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key Liquid Biopsy in Cancer Diagnostics companies such as Myriad Genetics Inc, Exact Sciences Corporation, Biocartis, Sysmex Corporation, Thermo Fisher Scientific Inc, Biocept Inc, among others.

Metastatic Colorectal Cancer Market

Metastatic Colorectal Cancer Market Insight, Epidemiology, and Market Forecast, 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key Metastatic Colorectal Cancer companies such as G1 Therapeutics, Amgen, Qilu Pharmaceutical, Eisai Co Ltd, Merck Sharp & Dohme, Mirati Therapeutics, among others.

Other Trending Oncological Market Reports

Cancer Pain Market
Cancer Pain Market Insight, Epidemiology, and Market Forecast, 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key Cancer Pain companies such as vTv Therapeutics, AstraZeneca, Janssen, among others.

Chronic Phase Chronic Myeloid Leukemia Market

Chronic Phase Chronic Myeloid Leukemia Market Insight, Epidemiology, and Market Forecast, 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key Chronic Phase Chronic Myeloid Leukemia companies such as Bristol-Myers Squibb, AOP Orphan Pharmaceuticals, Medical College of Wisconsin, Chia Tai Tianqing Pharmaceutical, among others.

Hormone Sensitive Advanced Prostate Cancer Market

Hormone Sensitive Advanced Prostate Cancer Market Insight, Epidemiology, and Market Forecast, 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key Hormone Sensitive Advanced Prostate Cancer companies such as Ferring Pharmaceuticals, among others.

Latest Healthcare Blogs

Top Five Prevalent Cancers in the World
Rare Cancer Market
Intratumoral Cancer Therapy

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.